Jørgen Søberg Petersen

Seed Investments

After 9 years in clinical and academic medicine in Denmark and in the United States, Jørgen spent 18 years in R&D Executive positions in Denmark, Switzerland, United States, France and Germany. Jørgen co-founded and built the Nasdaq-listed biotech company Zealand Pharma (ZEAL.CO), established the Immunology franchise at Merck, and has held leadership roles at Lundbeck and Novo Nordisk. He has industrial R&D experience across multiple therapeutic areas, including CNS, cardiovascular disease, diabetes, oncology and autoimmune disease, and has been involved in a number of major pharmaceutical licensing deals and alliances.

Jørgen holds MD, PhD, and DMSc degrees from the University of Copenhagen and an Executive MBA degree from the Technical University of Denmark.